Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07458880) titled 'Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control' on March 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: The University of Hong Kong
Condition:
Intracerebral Hemorrhage
Intervention:
Drug: Exforge HCT(R) or Three Individual drug amlodipine + valsartan + hydrochlorothiazide
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: March 1, 2026
Target Sample Size: 140
Countries of Recruitment:
Hong Kong
To...